FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:863-864 February 27, 2003 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Moses, H. PubMed Citation

To the Editor: I was disappointed to note that, in their discussion of the issues surrounding relationships between academia and the biomedical science and pharmaceutical industries, Moses et al. (Oct. 24 issue)¹ neglected to comment on one of the most frequent commercial ties that faculty members have — namely, being paid spokespersons for drug companies. Even a cursory review of this or any issue of the Journal would reveal the number of authors who are spokespersons for companies with which they also have a commercial research relationship. It is all too common that one receives invitations to attend "seminars" given . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.